| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
59,420,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
551,455 |
551,455 |
642,217 |
| Total Buy Value |
$0 |
$778,895 |
$778,895 |
$1,265,385 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
7 |
7 |
12 |
| Total Shares Sold |
0 |
4,890 |
11,122 |
27,899 |
| Total Sell Value |
$0 |
$7,922 |
$39,768 |
$125,583 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
2 |
4 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-23 |
4 |
AS |
$25.08 |
$2,942 |
I/I |
(116) |
666 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-23 |
4 |
AS |
$25.08 |
$1,584,606 |
D/D |
(62,493) |
30,950 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-06-23 |
4 |
AS |
$25.08 |
$1,587,548 |
I/I |
(62,609) |
666 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-22 |
4 |
AS |
$24.76 |
$2,695 |
I/I |
(108) |
782 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-22 |
4 |
AS |
$24.76 |
$1,458,784 |
D/D |
(58,469) |
93,443 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-06-22 |
4 |
AS |
$24.76 |
$1,461,479 |
I/I |
(58,577) |
782 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-21 |
4 |
AS |
$24.82 |
$2,931 |
I/I |
(118) |
890 |
|
- |
|
| Atlas Venture Associates Opportunity I, Llc |
10% Owner |
– – • |
2021-06-21 |
4 |
AS |
$24.82 |
$1,584,009 |
D/D |
(63,774) |
151,912 |
|
- |
|
| Rhodes Jason P |
Director |
– • – |
2021-06-21 |
4 |
AS |
$24.82 |
$1,586,940 |
I/I |
(63,892) |
890 |
|
- |
|
| Atlas Venture Opportunity Fund I, L.p. |
10% Owner |
– – • |
2021-06-16 |
4 |
AS |
$0.00 |
$0 |
I/I |
(100,000) |
1,266,937 |
|
- |
|
| Atlas Venture Opportunity Fund I, L.p. |
10% Owner |
– – • |
2021-06-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,000,000) |
8,111,939 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-06-15 |
4 |
AS |
$28.08 |
$42,120 |
D/D |
(1,500) |
198,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-06-15 |
4 |
OE |
$4.59 |
$6,885 |
D/D |
1,500 |
199,654 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-06-10 |
4 |
AS |
$27.23 |
$163,380 |
D/D |
(6,000) |
198,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-06-10 |
4 |
OE |
$4.59 |
$27,540 |
D/D |
6,000 |
204,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-27 |
4 |
AS |
$34.05 |
$51,075 |
D/D |
(1,500) |
198,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-27 |
4 |
OE |
$4.59 |
$6,885 |
D/D |
1,500 |
199,654 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-11 |
4 |
AS |
$31.05 |
$12,420 |
D/D |
(400) |
198,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-11 |
4 |
OE |
$0.60 |
$1,150 |
D/D |
400 |
198,554 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-10 |
4 |
AS |
$30.37 |
$263,114 |
D/D |
(8,600) |
198,154 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2021-05-10 |
4 |
OE |
$0.60 |
$5,160 |
D/D |
8,600 |
206,754 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2021-05-03 |
4 |
AS |
$35.47 |
$356,335 |
D/D |
(10,000) |
1,174,080 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2021-05-03 |
4 |
AS |
$35.54 |
$89,238 |
D/D |
(2,500) |
0 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2021-05-03 |
4 |
OE |
$4.59 |
$11,475 |
D/D |
2,500 |
2,500 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2021-04-23 |
4 |
AS |
$35.10 |
$351,000 |
D/D |
(10,000) |
1,184,080 |
|
- |
|
293 Records found
|
|
Page 8 of 12 |
|
|
